Logo image of ALC

ALCON INC (ALC) Stock Price, Forecast & Analysis

USA - NYSE:ALC - CH0432492467 - Common Stock

77.12 USD
-0.53 (-0.68%)
Last: 11/17/2025, 10:57:00 AM

ALC Key Statistics, Chart & Performance

Key Statistics
Market Cap38.54B
Revenue(TTM)9.91B
Net Income(TTM)1.07B
Shares499.70M
Float493.91M
52 Week High99.2
52 Week Low71.55
Yearly Dividend0.26
Dividend Yield0.45%
EPS(TTM)3
PE25.71
Fwd PE21.97
Earnings (Next)02-23 2026-02-23/amc
IPO2019-04-09
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


ALC short term performance overview.The bars show the price performance of ALC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10

ALC long term performance overview.The bars show the price performance of ALC in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 -5 10

The current stock price of ALC is 77.12 USD. In the past month the price increased by 3.38%. In the past year, price decreased by -8.79%.

ALCON INC / ALC Daily stock chart

ALC Latest News, Press Relases and Analysis

ALC Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
COO COOPER COS INC/THE 17.95 14.34B
SOLV SOLVENTUM CORP 12.78 13.16B
ALGN ALIGN TECHNOLOGY INC 13.94 9.77B
MMSI MERIT MEDICAL SYSTEMS INC 23.23 5.12B
LNTH LANTHEUS HOLDINGS INC 8.78 3.56B
HAE HAEMONETICS CORP/MASS 15.46 3.57B
ICUI ICU MEDICAL INC 17.1 3.36B
XRAY DENTSPLY SIRONA INC 6.65 2.10B
UFPT UFP TECHNOLOGIES INC 26.06 1.73B
NEOG NEOGEN CORP 21.35 1.39B
STAA STAAR SURGICAL CO N/A 1.30B
EMBC EMBECTA CORP 4.95 844.60M

About ALC

Company Profile

ALC logo image Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,599 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.

Company Info

ALCON INC

Rue Louis d'Affry 6

Fribourg FRIBOURG 1701 CH

CEO: David J. Endicott

Employees: 25000

ALC Company Website

ALC Investor Relations

Phone: 41589113800

ALCON INC / ALC FAQ

Can you describe the business of ALCON INC?

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,599 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.


Can you provide the latest stock price for ALCON INC?

The current stock price of ALC is 77.12 USD. The price decreased by -0.68% in the last trading session.


Does ALCON INC pay dividends?

ALCON INC (ALC) has a dividend yield of 0.45%. The yearly dividend amount is currently 0.26.


How is the ChartMill rating for ALCON INC?

ALC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the expected growth for ALC stock?

The Revenue of ALCON INC (ALC) is expected to grow by 5.28% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is ALCON INC worth?

ALCON INC (ALC) has a market capitalization of 38.54B USD. This makes ALC a Large Cap stock.


Can you provide the ownership details for ALC stock?

You can find the ownership structure of ALCON INC (ALC) on the Ownership tab.


ALC Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ALC. When comparing the yearly performance of all stocks, ALC is a bad performer in the overall market: 77.44% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ALC Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ALC. ALC has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALC Financial Highlights

Over the last trailing twelve months ALC reported a non-GAAP Earnings per Share(EPS) of 3. The EPS decreased by -0.66% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.7%
ROA 3.42%
ROE 4.85%
Debt/Equity 0.23
Chartmill High Growth Momentum
EPS Q2Q%-2.47%
Sales Q2Q%6.41%
EPS 1Y (TTM)-0.66%
Revenue 1Y (TTM)4.82%

ALC Forecast & Estimates

20 analysts have analysed ALC and the average price target is 107.72 USD. This implies a price increase of 39.68% is expected in the next year compared to the current price of 77.12.

For the next year, analysts expect an EPS growth of 1.39% and a revenue growth 5.28% for ALC


Analysts
Analysts79
Price Target107.72 (39.68%)
EPS Next Y1.39%
Revenue Next Year5.28%

ALC Ownership

Ownership
Inst Owners69.85%
Ins Owners0.12%
Short Float %1.21%
Short Ratio2.59